UNII 45P3261C7T

SODIUM CARBONATE

Unique Ingredient Identifier 45P3261C7T is listed as a ingredient substance
RN497-19-8
EC207-838-8
NCITC47721
RXCUI36685
PUBCHEM10340
MFCO3.2Na
INCHI KEYCDBYLPFSWZWCQE-UHFFFAOYSA-L
SMILES[Na+].[Na+].[O-]C([O-])=O

Alternate Names

Dosage Forms

UNII 45P3261C7T SODIUM CARBONATE is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION ADJPH
BUCCALGUM14.4 MG
BUCCALGUM, CHEWING30 MG
BUCCALTABLET20 MG
IM - IVINJECTION1.64 %
IM - IVPOWDER, FOR INJECTION SOLUTION63 %
INTRA-ARTERIALSOLUTION, INJECTION ADJPH
INTRAMUSCULARINJECTION1 %
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION NA
INTRAPERITONEALPOWDER, FOR INJECTION SOLUTION NA
INTRAPLEURALPOWDER, FOR INJECTION SOLUTION NA
INTRATUMORPOWDER, FOR INJECTION SOLUTION NA
INTRAVASCULARINJECTION ADJPH
INTRAVASCULARSOLUTION, INJECTION ADJPH
INTRAVENOUSINJECTION15.4 %W/W
INTRAVENOUSPOWDER575 MG
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION20.8 %
INTRAVENOUSSOLUTION, INJECTION ADJPH
IV - SCINJECTION ADJPH
IV(INFUSION)INJECTION24.1 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.18 %
NERVE BLOCKINJECTION ADJPH
OPHTHALMICSOLUTION0.01 %
ORALCAPSULE91.8 MG
ORALCAPSULE, DELAYED ACTION10 mg
ORALCAPSULE, SUSTAINED ACTION6 MG
ORALGRANULE, FOR ORAL SUSPENSION6.5 MG
ORALGUM, CHEWING10 MG
ORALINJECTION2.4 %W/V
ORALLOZENGE25 mg
ORALSUSPENSION, SUSTAINED ACTION6.5 MG/206.84 MG
ORALTABLET10.4 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED8 MG
ORALTABLET, DELAYED ACTION15 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED10 MG
ORALTABLET, EFFERVESCENT, FOR SOLUTION430 MG
ORALTABLET, EXTENDED RELEASE30 MG
ORALTABLET, FILM COATED30 MG
ORALTABLET, UNCOATED, LOZENGE8.55 MG
ORALTROCHE25 MG
RECTALPOWDER, FOR INJECTION SOLUTION NA
RECTALSUSPENSION NA
SUBLINGUALTABLET7.5 MG

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.